Compliance with good manufacturing practices for medicines in Brazil-Reference-Cited by-同舟云学术

Compliance with good manufacturing practices for medicines in Brazil

Published:2019-07-24 Issue:5 Volume:24 Page:351-360
ISSN:0949-1775
Container-title:Accreditation and Quality Assurance
language:en
Short-container-title:Accred Qual Assur

Author:

Geyer Andrea Renata Cornelio^ORCID,Sousa Varley Dias^ORCID,Silveira Dâmaris^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Safety, Risk, Reliability and Quality,Instrumentation,General Chemical Engineering,General Chemistry

Link

http://link.springer.com/content/pdf/10.1007/s00769-019-01395-7.pdf

Reference35 articles.

1. Sousa VD, Silveira D (2015) Regulatory transparency: social, technical, and ethical aspects of clinical trial data access. Rev Panam Salud Publica 37:430–434

2. WHO (2014) WHO good manufacturing practices for pharmaceutical products: main principles. WHO Tech Rep Ser 986:78–135 (Geneva, Switzerland)

3. WHO (2017) WHO member state mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products. http://www.who.int/medicines/regulation/ssffc/A70_23-en1.pdf?ua=1 . Accessed 16 July 2018

4. Johnston A, Holt DW (2014) Substandard drugs: a potential crisis for public health. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.12298

5. Nwokike J, Clark A, Nguyen PP (2018) Medicines quality assurance to fight antimicrobial resistance. Bull World Health Organ 96:135–137. https://doi.org/10.2471/BLT.17.199562

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recall of substandard medicines in Brazil during the period 2010–2018;BMC Health Services Research;2023-03-10

2. INSUMOS FARMACÊUTICOS ATIVOS (IFA) - DAS NECESSIDADES À PERVERSA REALIDADE BRASILEIRA;Infarma - Ciências Farmacêuticas;2021-03-30

3. Distributed Ledger Infrastructure to Verify adverse Event Reporting (DeLIVER): Proposal for a proof-of-concept study (Preprint);JMIR Research Protocols;2021-03-08